Intrinsic resistance to tyrosine kinase inhibitors is associated with poor clinical outcome in metastatic renal cell carcinomaJonas Busch, Viktor Grünwald, Stefan Hinz et al.|BMC Cancer|2011Cited by 54
Sequential mTOR inhibitor treatment with temsirolimus in metastatic renal cell carcinoma following failure of VEGF receptor tyrosine kinase inhibitorsSteffen Weikert, Ulrich Keilholz, Kurt Miller et al.|World Journal of Urology|2011Cited by 18
1774 SEQUENTIAL THERAPY OF PATIENTS WITH METASTASIZED KIDNEY CANCER REFRACTORY TO FIRST LINE TYROSINE KINASE INHIBITOR TREATMENTJonas Busch, Steffen Weikert, Christoph Seidel et al.|The Journal of Urology|2011Cited by 0